This regulatory milestone marks TISSIUM’s entry into the U.S. market and establishes the foundation of the TISSIUM polymer platform for atraumatic tissue repair Paris, France, Cambridge, USA, June 24, ...
Paris, France, Cambridge, USA, April 2 nd, 2025 - TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, is proud to unveil clinical data ...
Paris, France, Cambridge, USA, November 28, 2025 - TISSIUM, a Medical Technology company pioneering biomorphic programmable polymers for tissue reconstruction, announced today the first commercial use ...
TISSIUM Announces Clinical Results of COAPTIUM CONNECT System for Atraumatic Sutureless Nerve Repair
Paris, France, Cambridge, USA, April 2 nd, 2025 - TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, is proud to unveil clinical data ...
This regulatory milestone marks TISSIUM's entry into the U.S. market and establishes the foundation of the TISSIUM polymer platform for atraumatic tissue repair Paris, France, Cambridge, USA, June 24, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results